openPR Logo
Press release

Specialty Injectable Generics Industry Analysis by Market Size, Share, Outlook, and Forecast till 2026

06-28-2018 09:15 AM CET | Health & Medicine

Press release from: Worldwide Market Reports

Specialty Injectable Generics Industry

Specialty Injectable Generics Industry

Worldwide Market Reports added Latest Research Report titled “Global Specialty Injectable Generics Market by Manufacturers, Regions, Product Type and Application, Forecast up to 2026” to its Large Report database.

Specialty injectable generics are drug therapies used for the treatment of chronic or life threatening disease states that require administration by injection, infusion or inhalation and sold as generics. It is used in the treatment of infectious diseases, cardiovascular problems, autoimmune disorders, and in the field of oncology.

Get PDF of Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/197429

The higher efficacy of specialty injectable generics when compared to the conventional routes of drug administration has led to an increasing adoption of specialty injectable generics, thereby driving growth of the global specialty injectable generics market. Moreover, rising prevalence of diseases such as cancer, hepatitis C, and multiple sclerosis, and increasing number of patent expirations of blockbuster medication are also expected to boost growth of the specialty injectable generics market. Eloxatin, Alimta, Norditropin, and Remodulin are some of the major patent expirations in 2017.

However, complex process involved in the development of specialty generics, requirement of skilled workforce, and sourcing of raw materials are major factors that hamper growth of the global specialty injectable generics market.

Key Developments in Specialty Injectable Generics Market

Key players are adopting various strategies such as mergers, acquisitions, new product launches, expansions, collaborations, partnerships, approvals, and joint ventures to retain its position in the specialty injectable generics market. In September 2015, Pfizer acquired Hospira to expand its product portfolio of generic injectables and in May 2014, Hikma Pharmaceuticals acquired the U.S. generic injectable business of Bedford Laboratories to expand its product pipeline and strengthen its research and development activities.

Moreover, the generic version of Clolar known as clofarabine injection, which is used for the treatment of acute lymphoblastic leukemia was approved by the U.S Food and Drug Administration (FDA) in May 2017.

Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/197429

In 2014, Pfizer acquired InnoPharma, Inc., a generic injectable manufacturer specializing in the development of injectable for the treatment of cancer and CNS disorders. Furthermore, on April 20, 2018, Hikma Pharmaceuticals PLC announced that its wholly-owned U.S. subsidiary West-Ward Pharmaceuticals Corp. launched Dexrazoxane for injection, which is the generic equivalent to Zinecard.

Some of the major players operating in the global specialty injectable generics market include Pfizer Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Mylan N.V., Uman Pharma, Fresenius SE & Co. KGaA, Baxter, Par Pharmaceutical, Sagent Pharmaceuticals Inc., Teligent, and Hikma Pharmaceuticals PLC among others.

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

Contact Us:

Mr. Shah

Worldwide Market Reports

Tel: +1 415 871 0703

Email: sales@worldwidemarketreports.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Specialty Injectable Generics Industry Analysis by Market Size, Share, Outlook, and Forecast till 2026 here

News-ID: 1101377 • Views:

More Releases from Worldwide Market Reports

Manufacturing Roboticst Integration Solutions Market 2024 Industry Analysis, Size, Share, Growth, Trends, and Forecast 2024-2031 |FFT, Motoman Robotics, BOZHON, STEP
Manufacturing Roboticst Integration Solutions Market 2024 Industry Analysis, Siz …
The Manufacturing Roboticst Integration Solutions Market research report represents major insights on the current growth dynamics as well as the primary revenue generation elements that are available in the Manufacturing Roboticst Integration Solutions industry along with various other factors over the predicted period 2024-2031. The report on the Manufacturing Roboticst Integration Solutions market is focusing on a series of parameters including top manufacturing strategies, industry share, prime opportunities, industrial channels,
Lifestyle Health Engagement Solution Market Dynamic Growth Factors, and Outlook until 2031 |Welltok, Inc., Virgin Pulse, Limeade
Lifestyle Health Engagement Solution Market Dynamic Growth Factors, and Outlook …
The Lifestyle Health Engagement Solution Market Trends Overview 2024-2031: A new Report by Worldwide Market Reports, titled "Lifestyle Health Engagement Solution Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031," offers a comprehensive analysis of the industry, which comprises insights on the Lifestyle Health Engagement Solution market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. This report has a complete table of contents, figures,
Customized Healthcare Concierge Market Types and Applications, Drivers, Ongoing Trends, Future Demand, Challenges, Top Companies & Forecast 2024-2031 |HealthSapiens, MedVisit, PinnacleCare
Customized Healthcare Concierge Market Types and Applications, Drivers, Ongoing …
The Customized Healthcare Concierge Market research report represents major insights on the current growth dynamics as well as the primary revenue generation elements that are available in the Customized Healthcare Concierge industry along with various other factors over the predicted period 2024-2031. The report on the Customized Healthcare Concierge market is focusing on a series of parameters including top manufacturing strategies, industry share, prime opportunities, industrial channels, profit margin, etc.
Luxury Healthcare Real Estate Market Company Share, Major Competitors, Regional Segments, Strategies, and Forecast until 2031 |Welltower Inc., HCP, Inc., Ventas, Inc.
Luxury Healthcare Real Estate Market Company Share, Major Competitors, Regional …
The Luxury Healthcare Real Estate Market Trends Overview 2024-2031: A new Report by Worldwide Market Reports, titled "Luxury Healthcare Real Estate Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031," offers a comprehensive analysis of the industry, which comprises insights on the Luxury Healthcare Real Estate market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. This report has a complete table of contents, figures,

All 5 Releases


More Releases for Pharma

Antiemetics Market Size 2022 Analysis by Top Key Players| Acacia Pharma Group Pl …
Antiemetics Market research added by the Absolute Markets Insights, offers a comprehensive analysis of growth trends prevailing in the global business domain. This report also provides definitive data concerning market, size, commercialization aspects and revenue forecast of the industry. In addition, the study explicitly highlights the competitive status of key players within the projection timeline while focusing on their portfolio and regional expansion endeavors. Access the PDF sample of the report@
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the
Indometacin Market Top Key Manufacturers Aidarex, Ratiopharm, Merck, Xinhua Phar …
The Global Indometacin Market is a nonsteroidal anti-inflammatory drug commonly used as a prescription medication to reduce fever, pain, stiffness, and swelling from inflammation. The demand for nonsteroidal anti-inflammatory drug has been increasing owing to the emergence of anti-inflammatory biologics that are more targeted. However, such as side effects of anti-inflammatory drugs and patent expiry issues may hamper the market growth in the review period. For More Info, Get Sample Report
Hydroxycarbamide Market Study Report 2019| Taj Pharma, Beijing Jialin Pharma, Qi …
Los Angeles, United State, June 11, 2019, - The global Hydroxycarbamide market is expected to surge at a steady CAGR in the coming years, states the latest QY Research report. The publication offers an insightful take on the historical data of the market and the milestones it has achieved. The report also includes an assessment of current market trends and dynamics, which helps in mapping the trajectory of the global Hydroxycarbamide
TIGLUTIK Market 2019: Top Players are Sanofi, Mylan Pharma, Apotex, Glemark Gene …
TIGLUTIK Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry. Get Sample Copy of this Report@ https://www.researchreportsworld.com/enquiry/request-sample/13709986 Global TIGLUTIK market 2019 research provides a basic overview of the industry including definitions, classifications, applications